Europe – EMA Opens Consultation on Guideline for Advanced Therapies in Clinical Trials

The European Medicines Agency (EMA) on Thursday opened for consultation a new guideline on the structure and data requirements for a clinical trial application...

Europe – EMA Management Board: highlights of March 2024 meeting

EMA annual report 2023  The Board adopted EMA’s annual report for 2023. In 2023, EMA recommended 77 medicines for marketing authorisation for human use, 39 of which...

Europe – Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)...

12 new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended 12 medicines for approval at its March 2024 meeting. The CHMP recommended granting a marketing authorisation for Awiqli (insulin icodec)...
Trois nouvelles guidances du MDCG en Mars 2020

Europe – Regulatory requirements for conditional marketing authorization ‘evolving’

Regulatory requirements for conditional marketing authorizations (CMAs) are “evolving” and more complicated than in the past in terms of demonstrating a product’s major therapeutic...

Europe – Environmental risk assessment of medicinal products for human use

It is mandatory for a marketing authorisation application (MAA) for a medicinal product for human use (HMP) to include an environmental risk assessment (ERA)....
Joint Implementation/preparedness plan on the new Medical Devices Regulation 2017/745 (MDR) on March 11th, 2020

Europe – Accelerating stakeholder collaboration to enhance the clinical trials environment in the EU

The Accelerating Clinical Trials in the EU (ACT EU) initiative has established a multi-stakeholder platform (MSP) aimed at improving the environment for clinical trials across the European Union (EU). ACT...

UK – New treatment option available today for womb cancer

540 adults will have access to Dostarlimab (also called Jemperli and made by GSK). Dostarlimab is a monoclonal antibody and helps the immune system...

Europe – EU pharmaceutical policy: MEPs support comprehensive reform

On Tuesday, the Environment, Public Health and Food Safety Committee adopted its position on the new directive (66 votes in favour, two against and...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – European Parliament committee proposes changes to pharma legislation

The European Parliament’s health committee is set to debate and vote on changes to the proposed pharmaceutical legislation on 19 March, including provisions that...
Trois nouvelles guidances du MDCG en Mars 2020

Europe – EU regulators and industry clash on pharmaceutical reform package

European Union officials said a proposal to reform the EU pharmaceutical legislation will go a long way towards providing equal access to new medicines,...

NOS PROCHAINES FORMATIONS